Marrone bio innovations inc (MBII)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12Jun'12
Revenues:
Total revenues

9,650

6,694

6,966

6,997

8,716

5,719

5,425

5,752

4,324

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product

-

-

-

-

-

-

-

-

-

-

-

-

4,096

2,632

3,549

4,957

2,577

1,816

2,295

3,091

1,774

938

1,881

2,877

2,054

2,115

1,589

1,795

2,089

662

1,421

License

-

-

-

-

-

-

-

-

-

-

-

-

58

58

85

92

92

84

83

83

83

71

65

51

45

49

48

48

48

76

88

Related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13

97

183

199

89

254

206

605

110

296

205

54

-

-

Total revenues

-

-

-

-

-

-

-

-

-

-

4,219

6,476

4,154

2,690

3,634

5,049

2,669

1,913

2,475

3,357

2,056

1,098

2,200

3,134

2,704

2,274

1,933

2,048

2,191

738

1,509

Cost of product revenues

4,081

2,962

3,381

3,188

3,729

2,832

2,803

3,030

2,242

1,791

2,492

3,966

2,279

1,642

2,493

3,118

2,269

1,924

2,340

2,994

1,998

1,432

3,502

2,711

1,793

2,650

1,594

1,585

1,414

521

684

Gross profit

5,569

3,732

3,585

3,809

4,987

2,887

2,622

2,722

2,082

1,527

1,727

2,510

1,875

1,048

1,141

1,931

400

-11

135

363

58

-334

-1,302

423

911

-376

339

463

777

217

825

Operating Expenses:
Research, development and patent

3,234

3,690

3,760

3,634

2,942

2,976

2,658

2,493

2,535

2,371

3,152

2,853

2,444

2,373

2,662

2,313

2,322

3,308

3,442

3,328

3,422

5,903

4,817

4,264

4,297

6,227

4,454

3,941

3,283

-

-

Research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,350

2,415

Selling, general and administrative

7,993

8,196

9,598

6,604

5,674

5,218

4,161

4,746

5,030

4,224

5,174

5,073

5,343

4,714

3,754

4,512

5,530

5,887

5,317

7,411

7,887

9,312

7,394

5,920

6,324

4,526

4,527

3,117

2,847

2,617

2,166

Total operating expenses

11,227

11,886

13,358

10,238

8,616

8,194

6,819

7,239

7,565

6,595

8,326

7,926

7,787

7,087

6,416

6,825

7,852

9,195

8,759

10,739

11,309

15,215

12,211

10,184

10,621

10,753

8,981

7,058

6,130

5,967

4,581

Loss from operations

-5,658

-8,154

-9,773

-6,429

-3,629

-5,307

-4,197

-4,517

-5,483

-5,068

-6,599

-5,416

-5,912

-6,039

-5,275

-4,894

-7,452

-9,206

-8,624

-10,376

-11,251

-15,549

-13,513

-9,761

-9,710

-11,129

-8,642

-6,595

-5,353

-5,750

-3,756

Other (expense) income:
Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

4

8

10

15

22

14

6

9

17

21

11

10

24

24

0

1

10

4

Interest expense

337

460

355

353

306

298

300

340

1,119

1,065

804

869

636

390

755

759

1,037

749

687

659

669

669

769

863

606

715

1,122

2,251

1,968

593

601

Interest expense, related parties

-

-

-

-

-

0

0

17

434

1,098

1,098

1,085

1,074

1,383

1,099

1,083

796

-

501

-

-

-

0

-

-

-

-

-

-

-

-

Change in fair value of financial instruments

-

-

-

-

-

0

0

0

-5,177

-96

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

0

-3,730

-6,550

3,563

7,473

-435

Loss on extinguishment of debt, net

-

-

-

-

-

0

0

0

-2,196

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

49

-

-

-

Gain on extinguishment of debt, related party

-

-

-

-

-

0

0

0

9,183

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on modification of warrants

-

-

-1,564

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on issuance of new warrants

1,391

-

4,751

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration

237

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income, net

159

130

77

30

18

2

14

4

-31

-54

-29

-15

-7

-2

-81

-57

-6

1

-1

44

-3

-32

-139

-98

-9

-201

-67

-7

-7

4

6

Total other (expense) income, net

-1,332

-1,986

-6,593

-323

-288

-296

-286

-353

226

-2,313

-1,931

-1,969

-1,717

-1,771

-1,927

-1,889

-1,824

-1,824

-1,175

-609

-663

-684

-887

-950

-605

-892

2,565

4,341

-5,537

-8,052

-156

Loss before taxes

-6,990

-

-

-

-3,917

-

-

-

-

-

-

-

-

-7,810

-7,202

-6,783

-9,276

-11,030

-9,799

-10,985

-11,914

-16,233

-14,400

-10,711

-10,315

-12,021

-6,077

-2,254

-10,890

-

-

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13,802

-3,912

Income tax expense

34

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Net loss

-7,024

-10,140

-16,366

-6,752

-3,917

-5,603

-4,483

-4,870

-5,257

-7,381

-8,530

-7,385

-7,629

-7,810

-7,202

-6,783

-9,276

-11,030

-9,799

-10,985

-11,914

-16,233

-14,400

-10,711

-10,315

-12,021

-6,077

-2,254

-10,890

-

-3,912

Basic and diluted net loss per common share:

-0.05

-0.08

-0.14

-0.06

-0.04

-0.05

-0.04

-0.04

-0.07

-0.23

-0.27

-0.25

-0.31

-0.31

-0.29

-0.28

-0.38

-0.45

-0.40

-0.45

-0.49

-

-0.59

-

-

-

-

-

-

-

-3.13

Weighted-average shares outstanding used in computing basic and diluted net loss per common share:

141,572

134,328

116,186

110,723

110,691

111,186

110,568

108,647

74,591

56,163

31,351

29,401

24

24,841

24,460

24,598

24,569

24,481

24,465

24,465

24,465

-

24,421

-

-

-

-

-

-

-

1,251

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13,802

-3,912

Deemed dividend on convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,378

-

-

-

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,077

-3,632

-

-13,802

-

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.66

-

-0.52

-0.53

-0.63

-0.47

-2.84

-8.59

-10.94

-

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.66

-

-0.52

-0.53

-0.63

-0.80

-3.12

-8.59

-10.94

-

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24,464

-

20,775

19,518

19,246

12,888

1,277

1,268

1,262

-

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24,464

-

20,775

19,518

19,246

13,422

1,347

1,268

1,262

-

Product [Member]
Total revenues

9,535

6,570

6,859

6,882

8,601

5,604

5,310

5,637

4,224

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License [Member]
Total revenues

115

124

107

115

115

115

115

115

100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-